Rankings
▼
Calendar
FBLG Q1 2022 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
FBLG
FibroBiologics, Inc. Common Stock
$17M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$911,000
Net Income
-$1M
EPS (Diluted)
$-0.04
Cash Flow
Operating Cash Flow
-$763
Free Cash Flow
-$763
Stock-Based Comp.
$84
Balance Sheet
Total Assets
$0
Total Liabilities
$1M
Stockholders' Equity
-$1M
Cash & Equivalents
$407,000
← FY 2022
All Quarters
Q2 2022 →
